Cited by 850Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Open access

Sato, Douglas Kazutoshi, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Waters, Patrick J., Jorge, Frederico M. de Haidar, Takahashi, Toshiyuki, Nakashima, Ichiro, Apostolos-Pereira, Samira Luisa, Talim, Natalia, Simm, Renata Faria, Lino, Angelina Maria Martins, Misu, Tatsuro, Leite, Maria Isabel, Aoki, Masashi, Fujihara, Kazuo·2014·Neurology

DOI 10.1212/wnl.0000000000000101PMC PMC3937859

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays with live transfected cells. RESULTS: Among the 215 patients with NMOSD, 7.4% (16/215) were positive for MOG antibodies and 64.7% (139/215) were positive for AQP4 antibodies. No patients were positive for both antibodies. Patients with MOG antibodies represented 21.1% (16/76) of the patients negative for AQP4 antibodies. Compared with patients with AQP4 antibodies or patients who were seronegative, patients with MOG antibodies were more frequently male, had a more restricted phenotype (optic nerve more than spinal cord), more frequently had bilateral simultaneous optic neuritis, more often had a single attack, had spinal cord lesions distributed in the lower portion of the spinal cord, and usually demonstrated better functional recovery after an attack. CONCLUSIONS: Patients with NMOSD with MOG antibodies have distinct clinical features, fewer attacks, and better recovery than patients with AQP4 antibodies or patients seronegative for both antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000101

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. E., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,819
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study
Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Self-citation
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Mader, S., Gredler, V., Schanda, K., Rostasy, K. M., Dujmović, I., Pfaller, K., Lutterotti, A., Jarius, S., Pauli, F. D., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O’Connor, K. C., McLaughlin, K. A., Jager, P. L. D., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar‐Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 419
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 376

Show all 21 references

Sorted by citations

Items 701–800 of 848

Differentiation of acute-phase AQP4-IgG+ optic neuritis from CNS inflammatory diseases using optic nerve head blood flow analysis
Yamaguchi, C., Kiyota, N., Himori, N., Misu, T., Kaneko, K., Otomo, M., Takagi, A., Oshima, T., Kimura, R., Omodaka, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-19110-7 · Cited by 1
Medicare Part D Use and Costs for Immune-Mediated Neurologic Therapies
Wong, K., Zeng, E., Smith, T., King, J. B., Marini, E., Sorenson, A., Hwang, H., Stein, C., Francis, T., ROSE, J. W., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.38277 · Cited by 1
Impact of Autoantibody Status on Visual Outcomes in Severe Optic Neuritis Patients Without Multiple Sclerosis
Bhatele, P., Prabhu, A., & Pai, A. R. (2025) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2025.10474 · Cited by 1
Nationwide prevalence and incidence of MOG antibody-associated disease (MOGAD) in Denmark
Papp, V., Mamoei, S., Frederiksen, J. L., Nilsson, A. C., Svendsen, K. B., Christensen, J. R., Sellebjerg, F. T., Magyari, M., & Illés, Z. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107144 · Cited by 1
Monoclonal antibody efficacy in seropositive vs seronegative NMOSD: systematic review and meta-analysis
Zammar, K., Safan, A. S., Abushalbak, D. J., Daromar, A., Canibaño, B., AlHabil, Y., AbuAlrob, M. A., & Hamid, S. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578945 · Cited by 1
Congress report of the 2014 American Academy of Neurology annual meeting
Tanaka, M., & Kinoshita, M. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12141 · Cited by 1
血漿交換療法を行った抗myelin oligodendrocyte glycoprotein (MOG) 抗体陽性neuromyelitis optica spectrum disorderの1例
大城あずさ, 貞郎, 仲., Tamashiro, K., & 一男, 藤. (2016) · 脳と発達 · doi:10.11251/ojjscn.48.199 · Cited by 1
Neuroimaging in Pediatric Autoimmune Diseases
Longoni, G., & Banwell, B. (2017) · Journal of Pediatric Neurology · doi:10.1055/s-0037-1605580 · Cited by 1
Clinical Reasoning: A patient with a history of encephalomyelitis and recurrent optic neuritis
Gutman, J. M., Levy, M., Galetta, S. L., & Kister, I. (2017) · Neurology · doi:10.1212/wnl.0000000000004628 · Cited by 1
Clinical analysis of opticospinal multiple sclerosis (OSMS) presentation detecting anti-myelin oligodendrocyte glycoprotein (MOG) antibody
Kitagawa, S., Osada, T., Kaneko, K., Takahashi, T., Suzuki, N., & Nakahara, J. (2018) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001184 · Cited by 1
Biomarkers for Multiple Sclerosis
Velarde, A. T., Heras, S. M., & Guimerans, L. M. V. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00055 · Cited by 1
N2 year in review
Dalmau, J. O., Dalakas, M. C., Kolson, D. L., Paul, F., & Zamvil, S. S. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000644 · Cited by 1
Autoimmune Demyelinating Syndromes: Aquaporin-4-IgG-positive NMOSD and MOG - IgG Associated Disorder
Sechi, E., & Flanagan, E. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_15 · Cited by 1
Removed: Atypical Optic Neuritis
Zoric, L. D., & Čolak, E. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109654 · Cited by 1
The Importance of Optical Coherence Tomography in the Diagnosis of Atypical or Subclinical Optic Neuritis: A Case Series Study
Huang, Y.-M., Yang, G., Gustafsson, G., Gauffin, H., Landtblom, A., Mirabelli, P., & Link, H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041309 · Cited by 2
MOGAD: abordagem diagnóstica e terapêutica
Pizarro, C. K. J., Pacheco, A. V. G., & Íñiguez, J. A. C. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n2-033 · Cited by 1
Two cases of unilateral cortical fluid‐attenuated inversion recovery‐hyperintense lesions in anti‐ myelin oligodendrocyte glycoprotein‐associated encephalitis with seizures ( FLAMES )
Ishizawa, K., Iwasaki, O., Oka, H., Sugawara, T., Amari, M., Kawarabayashi, T., Okamoto, K., Kaneko, K., Takahashi, T., Ikeda, Y., et al. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12753 · Cited by 1
Uncovering the Diagnostic Challenge of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Case Study of Acute Bilateral Vision Loss
Anto, A. M., Allu, S. V. V., Acharya, S., Vakde, T., Omoregi, E., & Pandey, U. (2024) · Cureus · doi:10.7759/cureus.60612 · Cited by 1
Neuromyelitis optica in a young male patient: a case report and literature review
Ayen, A. A., Biyadgie, M., Yismaw, T. A., Damtew, A. B., Firew, N. G., Engedaw, H. A., Baye, M. L., Asfaw, T. D., Belay, B. M., & Kassa, B. D. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003328 · Cited by 1
Development of a clinical score to estimate the probability of neuromyelitis optica in patients presenting with optic neuritis
Terrim, S., Silva, G. D., Falcao, F. C. D. S. E. B., Silva, P. B. R., Faria, G. A. S., Filho, F. V. M., Piccolo, A. C., Comerlatti, L. R., de Oliveira, M. B., Adoni, T., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106523 · Cited by 1
Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability
Pimentel, V., & Becker, J. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1814370 · Cited by 1
Neuromyelitis Optica: Diagnosis and Treatment
Nakatsuji, Y., Kinoshita, M., Okuno, T., Takata, K., Koda, T., Honorat, J. A., Sakoda, S., & Mochizuki, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55594-0_8 · Cited by 1
NMO-Spektrum-Erkrankungen
Pfeuffer, S., Strippel, C., & Wiendl, H. (2017) · Aktuelle Neurologie · doi:10.1055/s-0042-124178 · Cited by 1
A case of recurrent myelitis associated with anti-myelin oligodendrocyte glycoprotein antibody that developed only as localized short spinal cord lesions
Matsumoto, A., Kaneko, K., Takahashi, T., Nakashima, I., Hisanaga, K., & Nagano, I. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001014 · Cited by 1
Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
Etemadifar, M., & Fazli, A. (2017) · Caspian Journal of Neurological Sciences · doi:10.29252/nirp.cjns.3.11.231 · Cited by 1
Anti-MOG Diseases
Filippi, M., & Rocca, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-38621-4_4 · Cited by 1
The neuromyelitis optica spectrum disorders
Szilasiová, J. (2019) · Neurologie pro praxi · doi:10.36290/neu.2019.059 · Cited by 1
Microcytic abnormalities of the inner retina in a patient with myelin oligodendrocyte glycoprotein (MOG) antibody–associated optic neuritis
Jang, Y., Kim, S., Kim, S.-J., & Jung, J. H. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04913-5 · Cited by 1
F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Phenotype in Myelin Oligodendrocyte Glycoprotein Antibody–Positive Autoimmune Epilepsy
Tripathi, M., Thankarajan, A. R. S., Tripathi, M., Garg, A. K., Ramanujam, B., Snigdha, & Bal, C. S. (2021) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_167_20 · Cited by 1
Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases
Tsagkas, C., Wendebourg, M. J., Mehling, M., Lorscheider, J., Lyrer, P. A., & Décard, B. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.721669 · Cited by 1
Imaging findings and diagnosis of atypical aggressive demyelinating lesions of the central nervous system
Paoletti, M., Muzic, S. I., Marchetti, F., Asteggiano, C., Pichiecchio, A., & Bastianello, S. (2021) · Journal of Radiological Review · doi:10.23736/s2723-9284.21.00116-7 · Cited by 1
The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience.
Nasehi, M. M., Ghofrani, M., Tabrizi, A., Gorji, F. A., & Khosravi, B. (2022) · Iranian journal of child neurology. · doi:10.22037/ijcn.v16i3.29322 · Cited by 1
Neuromyélite optique aiguë (maladie de Devic)
Nicolas, P., & Marignier, R. (2016) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(16)62856-7 · Cited by 1
Neuromyelitis optica: it is time to move one step further
Adoni, T. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170005 · Cited by 1
Improving longitudinal spinal cord atrophy measurements for clinical trials in multiple sclerosis by using the generalised boundary shift integral (GBSI)
Moccia, M. (2020) · UCL Discovery (University College London) · Cited by 1
Neurological complications of Sjögren’s syndrome
Ganesh, A., Lyons, S., & Yiin, G. S. C. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198806684.003.0019 · Cited by 1
Early initiation of steroid pulse therapy for neuromyelitis optica in an emergency room setting
Yamada, S., Oikawa, S., Komatsu, T., Hirai, T., Dohi, K., & Ogawa, T. (2015) · Acute Medicine & Surgery · doi:10.1002/ams2.155
2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis–European Committee for Treatment and Research in Multiple Sclerosis Meeting
Sato, D. K. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12171
Topics at the 7th congress of the Pan‐Asian Committee for Treatment and Research in Multiple Sclerosis held at Taipei in 2014
Matsushita, T., & Song, Z. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12209
Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody
Arrambide, G., Tur, C., & Montalbán, X. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514551457
MS and related disorders: looking for markers of phenotypes
Berg, D., & Deuschl, G. (2015)
The 8th Pan‐Asian Committee for Treatment and Research in Multiple Sclerosis
Nakamura, Y., & Matsushita, T. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12286
Bulbar myelitis – As an initial presentation of NMO associated with SLE
Patel, S. D., Anand, I., Batra, A. M., Rana, D. S., & Agrawal, R. (2016) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2016.01.009
Topics of neuromyelitis optica
Miyamoto, K. (2014) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.37.468
NMO-Spektrum-Erkrankungen
Pfeuffer, S., & Wiendl, H. (2016) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-016-1586-y
Neuro-Ophthalmology Annual Review
Golnik, K. C. (2015) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000147
抗MOG抗体が強陽性であったChronic relapsing inflammatory optic neuropathy（CRION）の1例
西川, 優., 奥, 英., 戸成, 匡., 菅澤, 淳., & 恒彦, 池. (2016) · 神経眼科 · doi:10.11476/shinkeiganka.33.27
Auto-anticorps anti-MOG et maladies inflammatoires démyélinisantes du système nerveux central
Vincent, T., & Chrétien, P. (2016) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(16)30241-6
Acute non compressive myelopathies
Cobo‐Calvo, Á. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Pregnancy Management in NMO: A Case of MOG- Antibody Positive NMO and Literature Review
Min, M., & Caruana, P. (2016) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000391
Caractéristiques cliniques des neuropathies optiques associées à la présence d’anticorps anti-MOG
Guern, G. L., Héron, E., & Benrabah, R. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.10.252
Boundary between multiple sclerosis and neuromyelitis optica
Nakashima, I. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12348
Neuromielite ottica acuta (malattia di Devic)
Nicolas, P., & Marignier, R. (2017) · EMC - Neurologia · doi:10.1016/s1634-7072(16)81775-4
Assessment and Diagnosis of Relapsing Multiple Sclerosis
Straus-Farber, R., & Miller, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-40628-2_3
A Comparison of Clinical Presentation and MRI Findings in Neuromyelitis optica Spectrum Disorder and Spinal Cord Infarct in Complex Patients with Multiple Co-Morbidities
Guerrero, B. L. (2017) · Journal of Neurology & Stroke · doi:10.15406/jnsk.2017.06.00201
Clinical Reasoning: A man with rapidly ascending paralysis
Rosenberg, J. B., Aradi, S. D., & Pruitt, A. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004156
Editorial: Induction of Central Nervous System Disease by the Adaptive Immune Response
Weissert, R., & Brilot, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01218
Recurrent Dysarthria and Ataxia in a Young Girl
Romba, M. C., Gonzalez‐Giraldo, E., & Levy, M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3085
Acute Disseminated Encephalomyelitis Followed by Recurrent or Monophasic Optic Neuritis
Waldman, A. T. (2017) · Springer eBooks · doi:10.1007/978-3-319-61407-6_37
Diagnostics différentiels de la sclérose en plaques
Brochet, B., Lebrun‐Frénay, C., Seze, J. D., Zéphir, H., Allart, E., Audoin, B., Ayrignac, X., Bensa, C., Blanchard-Dauphin, A., Brassat, D., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-2-294-75020-5.00003-x
To start immune therapy or not? An unusual presentation of longitudinally extensive transverse myelitis with pyrexia
Rounis, E., Leite, M. I., Pretorius, P. M., & Sen, A. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8879-7
血漿交換を要した抗myelin oligodendrocyte glycoprotein抗体陽性の急性散在性脳脊髄炎に続発する視神経炎の男児例
光平, 高., 知行, 高., 潤, 松., 西倉紀子, 底田, 辰., & 良浩, 丸. (2018) · 脳と発達 · doi:10.11251/ojjscn.50.276
Optic Neuritis
Burton, E. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811709-5.00019-3
Optic Neuritis as the Presenting Feature of Neuromyelitis Optica (NMO): Diagnosis and Management
McClelland, C. M., Lee, M. S., & Gans, M. S. (2019) · Springer eBooks · doi:10.1007/978-3-319-98455-1_2
Anti‐myelin Oligodendrocyte Glycoprotein Antibody‐positive Optic Neuritis in a Girl With Ulcerative Colitis
Konishi, K., Mizuochi, T., Takaki, Y., Ishihara, J., Suda, M., Takahashi, T., & Yamashita, Y. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002281
Estudo longitudinal dos aspectos clínicos, laboratoriais e imagenológicos de pacientes MOG-IgG positivo
Salles, L. (2019) · doi:10.11606/t.5.2019.tde-08052019-105906
Neuromyelitis Optica Spectrum Disorders
Galetta, K. M., & Matiello, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-16928-2_19
Caracterização do perfil de síndromes dolorosas, psicofísica e medidas de excitabilidade cortical em doentes com neuromielite óptica controlada
Valério, F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-01072019-150317
III. Multiple sclerosis
Nakashima, I. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.1470
Desenvolvimento do nanoimunossensor-AQP461-70 para o diagnóstico altamente específico e sensível de doenças do espectro da neuromielite óptica
dos Santos, A. D. S. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.99.2019.tde-30092019-085345
Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
Lohmann, L., Klotz, L., & Wiendl, H. (2020) · Neurologie up2date · doi:10.1055/a-0931-2592
Doença do Espectro Neuromielite Óptica (DENMO)
Azevêdo, B. K. G., Oliveira, M. S., Neto, V. A. M., Fukuda, J. S., & Fukuda, T. G. (2020) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v3i2.21
Anti-MOG associated myelitis
Isaykin, А. I., Voskresenskaya, O. N., Kuzminova, T. I., Ermilova, E. V., & Stezhko, O. V. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-3-87-92
The spectrum of anti-MOG associated demyelinating diseases in children: a review illustrated with clinical cases
Armindo, R. D. (2020) · Sinapse · doi:10.46531/sinapse/2020/ar/200007/2020
Comparaison clinico-épidémiologique des pathologies du spectre des neuromyélites optiques
Osswald, D., Seze, J. D., Collongues, N., & Speeg‐Schatz, C. (2020) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2019.11.011
Early Retinal Changes Following Paediatric Optic Neuritis
Wilbur, C. (2018) · TSpace (University of Toronto)
Acquired Paroxysmal Dyskinesia
Gupta, H., Mehta, S. H., & Sethi, K. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53721-0_6
Clinical outcomes of transverse myelitis with myelin oligodendrocyte glycoprotein antibody versus negative cases among adults in Isfahan, Iran: A comparative study
Etemadifar, M., Chitsaz, A., Rajabkhah, S., Tavakoli, H., Shafieyoun, A., Noorshargh, P., & Afzali, M. (2021) · Current Journal of Neurology · doi:10.18502/cjn.v19i4.5544
Clinical Approach to Pediatric Demyelinating Disease
Santoro, J. D., & Chitnis, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_29
Neuroimaging findings in MOGAD -- MRI and OCTPreprint
Bartels, F., Lu, A., Oertel, F. C., Finke, C., Paul, F., & Chien, C. (2021) · doi:10.22541/au.161530100.07337050/v1
Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
Lohmann, L., Klotz, L., & Wiendl, H. (2021) · Neuroradiologie Scan · doi:10.1055/a-1372-9203
Anti-MOG antibody associated long segment myelitis presenting as anterior cord syndrome
Datta, A. K., Mukherjee, A., Ray, B. K., & Biswas, A. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-240055
Autoantibodies, Encephalopathies, and Epilepsy
Matricardi, S., & Granata, T. (2021) · Progress in inflammation research · doi:10.1007/978-3-030-67403-8_6
Refractory hyponatremia in neuromyelitis optica in a pediatric patient
Lin, T., Hsu, P.-C., Sung, C.-C., Fang, H., Tien, C., Hu, C.-F., Wu, P.-W., Yu, C.-H., Ding, J.-J., Ho, S., et al. (2021) · Medicine · doi:10.1097/md.0000000000026231
Recurrent Bilateral Optic Neuritis Associated with Myelin Oligodendrocyte Glycoprotein Antibody: A Case Report from Nepal
Shah, S., Ojha, R., Sitaula, S., Regmi, D., Karn, R., Gajurel, B. P., Rajbhandari, R., Gautam, N., Paudel, S., & Shrestha, A. (2021) · Case Reports in Neurological Medicine · doi:10.1155/2021/8100423
Biomarcadores em Neurologia
Mescolotte, G. M., & Martins, C. R. (2019) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2019.18.3.11-17
Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
Lohmann, L., Klotz, L., & Wiendl, H. (2021) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1556-7008
Anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with cortical hyperintensity and pathologically confirmed extensive demyelination
Iwami, K., Takahashi‐Iwata, I., Eguchi, K., Nagai, A., Shirai, S., Matsushima, M., Yaguchi, H., Nakazato, S., Tanikawa, S., Tagawa, Y., et al. (2021) · Neuroimmunology Reports · doi:10.1016/j.nerep.2021.100032
Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
Avdeeva, V. E., & Котов, А. С. (2021) · Russian Journal of Child Neurology · doi:10.17650/2073-8803-2021-16-3-21-33
Atypical Presentation of Anti-MOG Ab Disease
Bhoi, S. K., Jha, M., Naik, S., Bag, A., Jaiswal, B. K., & Kumar, R. (2021) · Kansas Journal of Medicine · doi:10.17161/kjm.vol14.15494
Atteinte optique et protubérantielle atypique révélant une maladie liée aux anticorps anti-MOG
Fadil, K., Amriss, O., ElAssaad, H., ZAKARIAA, I., Merzem, A., Belgadir, H., Moussali, N., & Elbenna, N. (2022) · Journal d imagerie diagnostique et interventionnelle · doi:10.1016/j.jidi.2021.11.001
Myélopathies inflammatoires : de la SEP à la NMO
Collongues, N. (2022) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2021.12.004
Simultaneous screening for antibodies to myelin oligodendrocyte glycoprotein and aquaporin-4 in patients with optic neuritis using cell-based assay
Parthasarathy, D., Therese, K. L., Selvakumar, A., Krishnan, S., & Santhakumar, D. P. (2022) · Current Journal of Neurology · doi:10.18502/cjn.v21i1.9359
Diagnostic positif de la sclérose en plaques
Brochet, B., Lebrun‐Frénay, C., Seze, J. D., Zéphir, H., Allart, E., Audoin, B., Ayrignac, X., Bensa, C., Blanchard-Dauphin, A., Brassat, D., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-2-294-75020-5.00002-8
Mielopatie acute
Collongues, N., Kremer, S., & Seze, J. D. (2017) · EMC - Neurologia · doi:10.1016/s1634-7072(17)83854-x
Multiple sclerosis
Jia, X., Baranzini, S. E., & Hauser, S. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00018-7
MOG Antibody-Positive Myelopathy as a Paraneoplastic Manifestation of Lymphoma
Gil, S. D., Seok, J. I., & Kim, Y. S. (2022) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2022.4.9
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease With False-Positive Results in SARS-CoV-2 Antigen Tests: A Case Report
Yamamoto, N., Ikenouchi, H., Takai, Y., Endo, K., & Aoki, M. (2022) · Cureus · doi:10.7759/cureus.31514
Pediatric Optic Neuritis Post Vaccination: A Literature Review
Saputra, L. Y., Agustini, L., Gunawan, P. I., & Loebis, R. (2022) · International Journal of Research Publications · doi:10.47119/ijrp10011511220224282
Rare autoimmune and autoinflammatory neurologic disorders
Verma, N. K., Naik, R. R., Wong, B. H. S., Jayaraman, A., Fazil, M. H. U. T., Lim, K. Y., Cheam, M. S., Yuan, J. C. X., Ting, J. K. Y., Mamidi, A., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00019-5

Authors: Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., Lino, A. M. M., Misu, T., Leite, M. I., Aoki, M., & Fujihara, K.
Affiliations: Universidade Federal de Minas Gerais (BR)
From the Departments of Neurology (D.K.S., T.T., I.N., M.A.) and Multiple Sclerosis Therapeutics (T.M., K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology (D.C., F.M.d.H.J., S.L.A.-P., R.F.S., A.M.M.L.), Faculty of Medicine, University of São Paulo, Brazil; CIEM MS Research Center (M.A.L.-P., N.T.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; Neuroimmunology Group (P.J.W., M.I.L.), Nuffield Department of Clinical Neurosciences,...
ORCID: Sato, Douglas Kazutoshi
Callegaro, Dagoberto
Waters, Patrick J.
Takahashi, Toshiyuki
Nakashima, Ichiro
Lino, Angelina Maria Martins
Misu, Tatsuro
Leite, Maria Isabel
Aoki, Masashi
Fujihara, Kazuo
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-02-11
Volume: 82
Issue: 6
Pages: 474-481
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0000000000000101
PMC: PMC3937859
OpenAlex: W2103812851
Cited by: 850
References: 21
Citations by year: 2026: 25 · 2025: 41 · 2024: 45 · 2023: 67 · 2022: 69 · 2021: 94 · 2020: 95 · 2019: 83 · 2018: 76 · 2017: 82 · 2016: 66 · 2015: 66 · 2014: 38
FWCI: 62.41
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: Neurology (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Japan Society for the Promotion of Science (22229008)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: neuromyelitis optica spectrum disorder, anti-MOG antibodies, aquaporin-4 antibodies, seronegative NMOSD, clinical features, optic neuritis, spinal cord lesions, disease phenotypes, functional recovery, relapse rate
MeSH terms: Adolescent, Adult, Aged, Autoantibodies, Child, Preschool, Female, Humans, Male, Middle Aged, Neuromyelitis Optica, Phenotype, Sex Factors, Aquaporin 4, Young Adult, Myelin-Oligodendrocyte Glycoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks